Bausch Health (XSWX:VRX) FCF Margin % : 10.22% (As of Dec. 2023)

View and export this data going back to 2014. Start your Free Trial

What is Bausch Health FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Bausch Health's Free Cash Flow for the three months ended in Dec. 2023 was CHF213 Mil. Bausch Health's Revenue for the three months ended in Dec. 2023 was CHF2,082 Mil. Therefore, Bausch Health's FCF Margin % for the quarter that ended in Dec. 2023 was 10.22%.

As of today, Bausch Health's current FCF Yield % is 23.40%.

The historical rank and industry rank for Bausch Health's FCF Margin % or its related term are showing as below:

XSWX:VRX' s FCF Margin % Range Over the Past 10 Years
Min: -12.26 Med: 14.67 Max: 22.43
Current: 8.64

During the past 13 years, the highest FCF Margin % of Bausch Health was 22.43%. The lowest was -12.26%. And the median was 14.67%.

XSWX:VRX's FCF Margin % is ranked better than
75.15% of 1026 companies
in the Drug Manufacturers industry
Industry Median: -0.68 vs XSWX:VRX: 8.64

Bausch Health FCF Margin % Historical Data

The historical data trend for Bausch Health's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bausch Health FCF Margin % Chart

Bausch Health Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

14.22

9.99

13.55

-12.26

8.68

Bausch Health Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
FCF Margin %	Get a 7-Day Free Trial															17.28	5.30	8.08	10.55	10.22

Competitive Comparison of Bausch Health's FCF Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Bausch Health's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bausch Health's FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bausch Health's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Bausch Health's FCF Margin % falls into.

Bausch Health FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Bausch Health's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	657.248	/	7573.054
	=	8.68 %

Bausch Health's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	212.741	/	2082.438
	=	10.22 %

Bausch Health FCF Margin % Related Terms

Thank you for viewing the detailed overview of Bausch Health's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Bausch Health (XSWX:VRX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bausch Health Companies Inc (XSWX:VRX) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

BHC:USA BVF:Germany BHC:Canada

Address

2150 Saint Elzear Boulvard West, Laval, QC, CAN, H7L 4A8

Website

https://www.bauschhealth.com

Bausch Health Companies Inc is a global specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the dermatology, gastrointestinal, and ophthalmology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.

Bausch Health (XSWX:VRX) Headlines

No Headlines